Enhancer-mediated control of macrophage-specific arginase I expression

Journal of Immunology

Volumn 172, Issue 12, 2004, Pages 7565-7573

  Pauleau, Anne Laure ^a,d   Rutschman, Robert ^a   Lang, Roland ^a,e   Pernis, Alessandra ^c   Watowich, Stephanie S ^b   Murray, Peter J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; CYTOKINE; DEOXYRIBONUCLEASE I; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; STAT6 PROTEIN;

ANIMAL CELL; ARTICLE; ASTHMA; CHROMATIN; ENHANCER REGION; ENZYME SPECIFICITY; IMMUNE SYSTEM; IMMUNOPRECIPITATION; INFECTION; MACROPHAGE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 2942592246     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.12.7565     Document Type: Article

References (35)

1. Wu, G., and S. M. Morris, Jr. 1998. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336:1.
2. Morris, S. M. 2002. Regulation of enzymes of the urea cycle and arginine metabolism. Annu. Rev. Nutr. 22:87.
3. Wei, L. H., A. T. Jacobs, S. M. Morris, Jr., and L. J. Ignarro. 2000. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am. J. Physiol. 279:C248.
4. Wei, L. H., G. Wu, S. M. Morris, Jr., and L. J. Ignarro. 2001. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc. Natl. Acad. Sci. USA 98:9260.
5. Munder, M., K. Eichmarin, J. M. Moran, F. Centeno, G. Soler, and M. Modolell. 1999. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163:3771.
6. Bogdan, C., M. Rollinghoff, and A. Diefenbach. 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12:64.
7. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907.
8. Modolell, M., I. M. Corraliza, F. Link, G. Soler, and K. Eichmann. 1995. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25:1101.
9. Rutschman, R., R. Lang, M. Hesse, J. N. Ihle, T. A. Wynn, and P. J. Murray. 2001. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 166:2173.
10. Lee, J., H. Ryu, R. J. Ferrante, S. M. Morris, Jr., and R. R. Ratan. 2003. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc. Natl. Acad. Sci. USA 100:4843.
11. Mori, M., T. Murakami, Y. Haraguchi, A. Nishiyori, and M. Takiguchi. 1991. Structure and expression of genes for urea cycle enzymes. Contrib. Nephrol. 92:218.
12. Hesse, M., M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167:6533.
13. Zimmermann, N., N. E. King, J. Laporte, M. Yang, A. Mishra, S. M. Pope, E. E. Muntel, D. P. Witte, A. A. Pegg, P. S. Foster, et al. 2003. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J. Clin. Invest. 111:1863.
14. Wynn, T. A. 2003. IL-13 effector functions. Annu. Rev. Immunol. 21:425.
15. Vincendeau, P., A. P. Gobert, S. Daulouede, D. Moynet, and M. D. Mossalayi. 2003. Arginases in parasitic diseases. Trends Parasitol. 19:9.
16. Iniesta, V., L. C. Gomez-Nieto, and I. Corraliza. 2001. The inhibition of arginase by N(ω)-hydroxy-L-arginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 193:777.
17. Iniesta, V., L. C. Gomez-Nieto, I. Molano, A. Mohedano, J. Carcelen, C. Miron, C. Alonso, and I. Corraliza. 2002. Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol. 24:113.
18. Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. Vignali, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630.
19. Lang, R., R. L. Rutschman, D. R. Greaves, and P. J. Murray. 2002. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J. Immunol. 168:3402.
20. Lang, R., D. Patel, J. J. Morris, R. L. Rutschman, and P. J. Murray. 2002. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169:2253.
21. 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU. 1. J. Biol. Chem. 277:19001.
22. Wooten, D. K., X. Xie, D. Bartos, R. A. Busche, G. D. Longmore, and S. S. Watowich. 2000. Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D. J. Biol. Chem. 275:26566.
23. Mori, M., T. Gotoh, A. Nagasaki, M. Takiguchi, and T. Sonoki. 1998. Regulation of the urea cycle enzyme genes in nitric oxide synthesis. J. Inherited Metab. Dis. 21(Suppl. 1):59.
24. Takiguchi, M., Y. Haraguchi, and M. Mori. 1988. Human liver-type arginase gene: structure of the gene and analysis of the promoter region. Nucleic Acids Res. 16:8789.
25. Takiguchi, M., and M. Mori. 1991. In vitro analysis of the rat liver-type arginase promoter. J. Biol. Chem. 266:9186.
26. Takiguchi, M., and M. Mori. 1995. Transcriptional regulation of genes for ornithine cycle enzymes. Biochem. J. 312:649.
27. Mori, M., and T. Gotoh. 2000. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem. Biophys. Res. Commun. 275:715.
28. Schjerven, H., P. Brandtzaeg, and F. E. Johansen. 2000. Mechanism of IL-4-mediated up-regulation of the polymeric Ig receptor: role of STAT6 in cell type-specific delayed transcriptional response. J. Immunol. 165:3898.
29. Schroder, A. J., P. Pavlidis, A. Arimura, D. Capece, and P. B. Rothman. 2002. Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes. J. Immunol. 168:996.
30. Escalante, C. R., A. L. Brass, J. M. Pongubala, E. Shatova, L. Shen, H. Singh, and A. K. Aggarwal. 2002. Crystal structure of PU. 1/1RF-4/DNA ternary complex. Mol. Cell 10:1097.
31. Tominaga, N., K. Ohkusu-Tsukada, H. Udono, R. Abe, T. Matsuyama, and K. Yui. 2003. Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4. Int. Immunol. 15:1.
32. Gupta, S., M. Jiang, A. Anthony, and A. B. Pernis. 1999. Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 190:1837.
33. Fanzo, J. C., C. M. Hu, S. Y. Jang, and A. B. Pernis. 2003. Regulation of lymphocyte apoptosis by interferon regulatory factor 4 (IRF-4). J. Exp. Med. 197:303.
34. Hu, C. M., S. Y. Jang, J. C. Fanzo, and A. B. Pernis. 2002. Modulation of T cell cytokine production by interferon regulatory factor-4. J. Biol. Chem. 277:49238.
35. Sandor, M., J. V. Weinstock, and T. A. Wynn. 2003. Granulomas in schistosome and mycobacterial infections: a model of local immune responses. Trends Immunol. 24:44.